Table 1.
Demographic, clinical, and laboratory characteristics of the participants
| Rosacea group (n=40) | Control group (n=40) | P | |
|---|---|---|---|
| n (%) / mean ± SD | n (%) / mean ± SD | ||
| Age (years) | 50.35 ± 7.59 | 50.52 ± 7.96 | 0.867 |
| Smoking | 4 (10%) | 6 (15%) | 0.499 |
| Alcohol consumption | 2 (5%) | 2 (5%) | 1 |
| Regular exercise | 16 (40%) | 23 (57.5%) | 0.117 |
| Family history of CVD | 5 (12.5%) | 6 (15%) | 0.815 |
| EFT (mm) | 4.46 ± 0.65 | 3.28 ± 0.59 | < 0.001 |
| CIMT (mm) | 0.72 ± 0.19 | 0.61 ± 0.12 | < 0.001 |
| LDL (mg/dL) | 133.74 ± 33.39 | 121.76 ± 24.68 | 0.058 |
| TG (mg/dL) | 141.45 ± 75.06 | 123.24 ± 59.11 | 0.177 |
| Total Cholesterol (mg/dL) | 215.54 ± 40.78 | 206.31 ± 30.45 | 0.216 |
| HDL (mg/dL) | 53.89 ± 12.31 | 59.87 ± 16.98 | 0.067 |
| FBG (mg/dL) | 95.97 ± 14.96 | 94.49 ± 11.46 | 0.791 |
| CRP (mg/dL) | 3.16 ± 3.16 | 2.26 ± 1.99 | 0.090 |
| BMI (kg / m2) | 27.75 ± 3.08 | 27.14 ± 3.52 | 0.597 |
| Systolic BP (mm Hg) | 123.14 ± 16.94 | 114.36 ± 14.11 | 0.045 |
| Diastolic BP (mm Hg) | 80 ± 10.57 | 74.61 ± 6.82 | 0.016 |
| HOMA-IR | 2.41 ± 1.31 | 2.14 ± 1.19 | 0.329 |
| HOMA-IR > 2.7 | 14 (35%) | 10 (25%) | 0.329 |
| MS | 13 (32.5%) | 8 (20%) | 0.204 |
Chi-square test, Independent samples t test, and Mann-Whitney U-test. SD- Standard deviation; CVD- Cardiovascular disease; EFT- Epicardial fat thickness; CIMT- Carotid intima-media thickness; TG-Triglyceride; FBG- Fasting blood glucose; BMI- Body mass index; BP- Blood pressure; HOMA-IR- Homeostasis model assessment of insulin resistance; MS- Metabolic syndrome.